Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
Rui Sun, Rowland H. Han, Colin McCornack, et al.
Science Advances (2023) Vol. 9, Iss. 19
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Border-associated macrophages in the central nervous system
Rui Sun, Haowu Jiang
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Mekenzie Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 5, pp. 826-839
Open Access | Times Cited: 17
Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 11, pp. 1048-1060
Open Access | Times Cited: 34
Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
Shengwen Shao, Huilai Miao, Wenxue Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
Jian Zhong, Xudong Xing, Yixin Gao, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 968-984.e9
Closed Access | Times Cited: 8
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Macrophages and T cells in metabolic disorder-associated cancers
Daniel Taranto, Daan J. Kloosterman, Leila Akkari
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Linking macrophage metabolism to function in the tumor microenvironment
Robbie Jin, Luke Neufeld, Tracy L. McGaha
Nature Cancer (2025)
Closed Access | Times Cited: 1
Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer’s Disease
Jian Shi, Shi‐Wei Huang
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 16-16
Open Access | Times Cited: 19
Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways
Yunji Yan, Shengwei Bai, Hongxi Han, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Deciphering microglia phenotypes in health and disease
Christopher Balak, Claudia Z. Han, Christopher K. Glass
Current Opinion in Genetics & Development (2024) Vol. 84, pp. 102146-102146
Open Access | Times Cited: 6
Revealing the role of SPP1+ macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomas
Wenshu Tang, Cario W. S. Lo, Wei Ma, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages
Xuezhen Chen, Yue Zhao, Yimin Huang, et al.
Glia (2023) Vol. 71, Iss. 11, pp. 2679-2695
Open Access | Times Cited: 14
Targeting immune checkpoints on myeloid cells: current status and future directions
Chuhan Ma, Yang Li, Min Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia
T. J. Stone, Jessica C. Pickles, Olumide Ogunbiyi, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
TREM2 scFv‐Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio‐Immunotherapy
Yifan Wang, Anqi Dong, Jianping Man, et al.
Advanced Materials (2025)
Closed Access
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination
Jinchao Hou, Roberta Magliozzi, Yun Chen, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 13
Open Access
TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas
Jiaying Zheng, Lingxiao Wang, Shunyi Zhao, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 5, pp. 811-825
Open Access | Times Cited: 12
Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth
Alberto Rivera-Ramos, Luis Cruz-Hernández, Rocío Talaverón, et al.
Cancer Letters (2024) Vol. 591, pp. 216879-216879
Open Access | Times Cited: 4
Mechanisms of TREM2 mediated immunosuppression and regulation of cancer progression
Lei Xia, Ya Ni Gou, Jin Yong Hao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Autophagy in glioblastoma: A mechanistic perspective
Durgesh Meena, Sushmita Jha
International Journal of Cancer (2024) Vol. 155, Iss. 4, pp. 605-617
Closed Access | Times Cited: 4
A bird’s eye view to the homeostatic, Alzheimer and Glioblastoma attractors
Joan Nieves, Gabriel Gil, Augusto González
Heliyon (2025) Vol. 11, Iss. 4, pp. e42445-e42445
Open Access
Machine learning-assisted design of immunomodulatory lipid nanoparticles for delivery of mRNA to repolarize hyperactivated microglia
Mehrnoosh Rafiei, Akbar Shojaei, Ying Chau
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
Laura M. Bartos, Sabrina V. Kirchleitner, Zeynep Ilgin Kolabas, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 10
Current understanding on TREM-2 molecular biology and physiopathological functions
Shiv Bharadwaj, Yaroslava Groza, Joanna Maria Mierzwicka, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112042-112042
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top